Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Tenon Medical, Inc. Warrant (TNONW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: TNONW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -44.44% | Avg. Invested days 7 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.01 - 0.09 | Updated Date 02/26/2025 |
52 Weeks Range 0.01 - 0.09 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Tenon Medical, Inc. Warrant
Company Overview
History and Background
Tenon Medical, Inc. is a medical device company focused on transforming spine surgery with minimally invasive solutions for the treatment of the Sacroiliac Joint (SI Joint). Founded in 2012, they've focused on SI joint fusion.
Core Business Areas
- SI Joint Fusion: Development, manufacturing, and commercialization of minimally invasive surgical solutions for SI joint fusion. This includes their CATAMARAN SI Joint Fusion System.
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives overseeing various departments such as sales, marketing, R&D, and operations. The organizational structure is typical for a medical device company, with departments focused on product development, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- CATAMARAN SI Joint Fusion System: Tenon Medical's flagship product, designed for minimally invasive SI joint fusion. Market share is still developing. Competitors include SI-BONE (SIBN), Medtronic (MDT), and RTI Surgical (RTIX).
Market Dynamics
Industry Overview
The spinal implant and SI joint fusion market is growing, driven by an aging population, increasing prevalence of back pain, and advancements in minimally invasive surgical techniques.
Positioning
Tenon Medical aims to be a leader in minimally invasive SI joint fusion with its proprietary CATAMARAN system. Their competitive advantage lies in the potential for reduced recovery time and improved patient outcomes.
Total Addressable Market (TAM)
The estimated TAM for SI joint fusion is in the hundreds of millions of dollars annually. Tenon is positioned to capture a portion of this market through adoption of its CATAMARAN system.
Upturn SWOT Analysis
Strengths
- Proprietary CATAMARAN SI Joint Fusion System
- Minimally invasive approach
- Focus on SI joint fusion
- Strong intellectual property portfolio
Weaknesses
- Limited commercial history
- Reliance on a single product
- Small market share compared to larger competitors
- Need for more clinical data
Opportunities
- Growing demand for minimally invasive spine surgery
- Expanding indications for SI joint fusion
- Potential for partnerships with larger medical device companies
- International market expansion
Threats
- Competition from established players
- Reimbursement challenges
- Regulatory hurdles
- Potential for product liability claims
Competitors and Market Share
Key Competitors
- SIBN
- MDT
- RTI Surgical (RTIX)
Competitive Landscape
Tenon Medical is a smaller player in a competitive market dominated by larger companies. Their advantage lies in their specialized focus on SI joint fusion and their proprietary technology. Their disadvantage is their smaller scale and limited resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is recent as the company continues to commercialize their product, showing an increase in product adoption and revenue.
Future Projections: Future growth depends on continued adoption of the CATAMARAN system and expansion into new markets. Analyst estimates predict significant revenue growth, but profitability remains uncertain.
Recent Initiatives: Recent initiatives include expanding the sales team, conducting clinical studies, and securing regulatory approvals.
Summary
Tenon Medical is a medical device company with a promising technology in the growing SI joint fusion market. While the company faces stiff competition and is not yet profitable, it has strong revenue growth and a focused approach. Key to success is further market penetration, clinical data validation, and efficient scaling. They need to watch out for cash burn rates and competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. The information provided is based on publicly available data and analyst estimates, which are subject to change. Past performance is not indicative of future results. Investing in warrants carries significant risk, including the potential for complete loss of investment.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tenon Medical, Inc. Warrant
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-06-15 | CEO - | ||
Sector Healthcare | Industry Medical Devices | Full time employees 22 | Website |
Full time employees 22 | Website | ||
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.